| Identification | Back Directory | [Name]
METHYL 6-O-TOSYL-ALPHA-D-GLUCOPYRANOSIDE | [CAS]
6619-09-6 | [Synonyms]
Methyl 6-O-tosyl-a-D-glucopyranoside
Methyl 6-O-Tosyl-α-D-glucopyranoside
METHYL 6-O-TOSYL-ALPHA-D-GLUCOPYRANOSIDE
Methyl 6-O-tosyl-alpha-D-galactopyranoside
Methyl 6-O-(4-methylphenyl)sulfonyl-α-D-glucopyranoside
α-D-Glucopyranoside, methyl, 6-(4-methylbenzenesulfonate)
Methyl α-?D-?Glucopyranoside 6-?(4-?Methylbenzenesulfona?te)
methyl 6-O-((4-methylphenyl)sulfonyl)-alpha-D-galactopyranoside | [Molecular Formula]
C14H20O8S | [MDL Number]
MFCD00047527 | [MOL File]
6619-09-6.mol | [Molecular Weight]
348.37 |
| Chemical Properties | Back Directory | [Melting point ]
123-125 °C | [Boiling point ]
550.2±50.0 °C(Predicted) | [density ]
1.47±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [pka]
12.81±0.70(Predicted) |
| Hazard Information | Back Directory | [Uses]
Methyl α-?D-?Glucopyranoside 6-?(4-?Methylbenzenesulfona?te) is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins. |
|
| Company Name: |
Carbosynth
|
| Tel: |
+86 512 6260 5585 |
| Website: |
www.carbosynth.com |
|